407 studies found for:    PAH
Show Display Options
RSS Create an RSS feed from your search for:
PAH
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Nitric Oxide;   Other: Placebo
2 Recruiting Bardoxolone Methyl Evaluation in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Bardoxolone methyl;   Drug: Placebo
3 Recruiting Training With Whole Body Vibration Device in Patients With PAH
Condition: Pulmonary Artery Hypertension
Intervention: Device: Exercise Group Galileo PAH
4 Recruiting Obstructive Sleep Apnea in Pulmonary Arterial Hypertension (OSA in PAH)
Conditions: Pulmonary Arterial Hypertension;   Obstructive Sleep Apnea
Intervention:
5 Recruiting BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Dietary Supplement: Beetroot juice
6 Recruiting Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Condition: Pulmonary Arterial Hypertension
Intervention:
7 Recruiting Hormonal, Metabolic, and Signaling Interactions in PAH
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:
8 Active, not recruiting Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
Conditions: Thalassemia Major;   Thalassemia Intermedia;   Pulmonary Arterial Hypertension
Intervention: Other: Physician standard-of-care according to ESC/ERS Guidelines
9 Not yet recruiting Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
Conditions: Pulmonary Arterial Hypertension;   PAH
Intervention: Drug: Macitentan
10 Completed An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Beraprost Sodium Modified Release
11 Recruiting A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain
Condition: Pulmonary Arterial Hypertension (PAH)
Intervention: Drug: Macitentan
12 Terminated
Has Results
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: treprostinil;   Device: Crono Five ambulatory pump
13 Recruiting SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
14 Completed
Has Results
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sitaxentan sodium
15 Completed Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)
Condition: Pulmonary Arterial Hypertension
Intervention:
16 Recruiting FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Placebo;   Drug: FK506 level < 2 ng/ml;   Drug: FK506 level 2-3 ng/ml;   Drug: FK506 level 3-5 ng/ml
17 Recruiting Auto-immunity and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   HIV Infection;   Congenital Heart Defect;   Systemic Sclerosis;   Connective Tissue Disease
Interventions: Procedure: skin biopsy;   Other: Blood Sample
18 Completed Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Beraprost Sodium Modified Release
19 Completed Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil;   Drug: Sugar Pill
20 Completed Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Beraprost Sodium Modified Release

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years